Opium as a risk factor for upper gastrointestinal cancers: A population-based case-control study in Iran

Ahmad Naghibzadeh Tahami, Narges Khanjani, Vahid Yazdi Feyzabadi, Masoomeh Varzandeh, Ali-Akbar Haghdoost

Research output: Contribution to journalArticleResearchpeer-review

45 Citations (Scopus)

Abstract

BACKGROUND: Gastrointestinal cancers, including esophageal, gastric, liver and pancreatic are relatively common in Iran. Furthermore, consumption of opium and its derivatives (O&D) are considerable. This study, aimed to examine the association between consumption of O&D and the incidence of upper gastrointestinal (UGI) cancers. METHODS: In a matched case-control study in Kerman (located in southeast of Iran), 142 patients with UGI cancers and 284 healthy people (matched in terms of age, sex and residence (urban/rural)) were recruited. Variables (using O&D, smoking, alcohol use and diet) were collected using a structured questionnaire. Conditional logistic regression models were used to assess the above mentioned association. RESULTS:Opium use was associated with an increased risk of UGI cancers with an adjusted OR 4.0 (95 % CI: 2.2 - 7.0). A very strong dose-response relation was observed between consumption of O&D and the incidence of UGI cancers. (Three consumption levels-none, low and high; OR = 18.7; 95 % CI: 5.5 - 63.3). This dose-response relationship was also strong even in patients with gastric cancers (OR: 9.2; 95 % CI: 2.5 - 33.7). Conclusion: The results of this study showed that opium consumption can be a strong risk factor for UGI cancers in Iran.

Original languageEnglish
Pages (from-to)2-6
Number of pages5
JournalArchives of Iranian Medicine
Volume17
Issue number1
Publication statusPublished - Jan 2014
Externally publishedYes

Keywords

  • Case-control
  • Iran
  • Opium
  • Risk factors
  • UGI neoplasms

Cite this